Previous studies compared ICAM-1 K469E polymorphisms between MI and CHD group as a whole.7, 14 In our work, there were no significant differences in sICAM-1 levels between CHD patients and control subjects (P=.37) and no significant differences in sICAM-1 levels among patients with different genotypes (P=.53). This evidence concerns the gene ICAM1 and myocardial infarction.